Vyriad launches IMMUNO-COV™, the first scalable neutralizing antibody test for COVID-19 Read More

In the News

August 31, 2020

Heroes of the Pandemic

Star Tribune

June 12, 2020

Mayo Clinic Unveils New Antibody Test for COVID-19

KARE 11 News

June 11, 2020

Mayo Clinic Unveils Key COVID-19 Antibody Test

Star Tribune

June 11, 2020

Vyriad CEO Stephen Russell discusses neutralizing antibody testing

Myeloma Crowd Radio

May 22, 2020

University of Minnesota’s Infectious Disease Center Urges Better Use of COVID-19 Testing

Star Tribune

May 13, 2020

Rochester Scientists Develop First-of-its-Kind Antibody Test to Detect Protective Immunity

Med City Beat

March 4, 2020

Dr. Stephen Russell Participates in “Creating a Cluster of Innovation in Rochester” Podcast

Finance & Commerce

November 21, 2019

Rochester Cancer-Therapy Firm to Collaborate with Drugmaker on Melanoma Treatment

Star Tribune

November 6, 2019

Rochester Biotech Firm Strikes ‘Significant’ Deal with Drug Maker

Rochester Post-Bulletin

September 3, 2019

From Concept to Company: An Anti-Cancer Idea Goes Viral

Discovery's Edge

March 8, 2019

Vyriad: Hoping to Cure Cancer with a Single Shot

Post-Bulletin

January 31, 2019

Vyriad Moves to Former IBM Complex

KIMT

January 17, 2019

State of the Art Cancer Therapeutics Manufacturing Headquarters Celebrates Grand Opening in Rochester Next Week

Rochester Rising

July 27, 2018

Vyriad Expands Phase 1 Trial to Test Voyager-V1 in Combination with Bevencio for Colorectal Cancer

Immuno-Oncology News

June 11, 2018

Mayo Clinic patient treated by massive measles dose still cancer-free 5 years later

Star Tribune

March 28, 2018

Mayo Clinic Biotech Spin-Off Vyriad Raising $9M for Expansion, Clinical Trials

Twin Cities Business

August 13, 2017

Oncolytic Virotherapy: A New Cornerstone for Immuno-Oncology

Journal of Oncology

August 8, 2014

Giving Viruses a License to Kill… Cancer

Science Friday